Piramal Pharma Solutions Clears 200 Audits, Secures 70 Regulatory Approvals
Event summary
- Piramal Pharma Solutions completed over 200 customer audits and received 70 regulatory approvals in the past fiscal year.
- The company's quality strategy focuses on governance, digital transformation, and workforce development.
- Key initiatives include the RESOLVE program for manufacturing and QC labs, and AI-enabled tools like iAssist.
- PPS operates a global network of facilities across North America, Europe, and Asia.
The big picture
Piramal Pharma Solutions' strong audit performance underscores its commitment to quality and compliance, critical factors in the highly regulated pharmaceutical manufacturing sector. The company's focus on digital transformation and governance aligns with broader industry trends toward automation and data-driven decision-making. With a global network of facilities, Piramal is positioning itself as a reliable partner for end-to-end drug development and manufacturing solutions.
What we're watching
- Regulatory Compliance
- How Piramal's sustained audit readiness will impact its ability to secure future regulatory approvals.
- Digital Transformation
- The pace at which digital tools like iAssist and eLab will enhance operational efficiency.
- Market Positioning
- Whether Piramal can maintain its competitive edge in the CDMO space through quality-focused strategies.
Related topics